Breaking News
Get 55% Off 0
NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stock
Read More
Close

Axa Spdb Growth Flexible Allocate A (519170)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.846 -0.026    -3.04%
22/11 - Closed. Currency in CNY
Type:  Fund
Market:  China
Issuer:  AXA SPDB Investment Managers Co.,Ltd
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 566.53M
AXA SPDB Growth flexible allocate 0.846 -0.026 -3.04%

519170 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the AXA SPDB Growth flexible allocate (519170) fund. Our AXA SPDB Growth flexible allocate portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 13.410 13.410 0.000
Stocks 87.780 87.780 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 19.915 17.577
Price to Book 2.455 2.212
Price to Sales 1.825 1.726
Price to Cash Flow 12.278 9.656
Dividend Yield 1.047 2.492
5 Years Earnings Growth 25.244 16.876

Sector Allocation

Name  Net % Category Average
Technology 66.690 24.851
Industrials 20.510 24.258
Consumer Defensive 8.240 10.946
Communication Services 2.790 4.138
Consumer Cyclical 1.110 11.033
Real Estate 0.490 3.069
Basic Materials 0.140 11.743
Healthcare 0.030 9.773

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 57

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Luxshare Precision A CNE100000TP3 9.25 37.65 -4.03%
  Shandong Zhongji Electrical CNE100001CY9 6.36 132.28 -1.14%
  Bestechnic Shanghai Co CNE100005XM1 5.55 254.00 -0.66%
  Shenzhen Mtc A CNE100000Q50 4.90 4.93 -3.90%
  GigaDevice Semiconductor CNE1000030S9 4.72 84.38 -4.46%
  Avary CNE100003GF5 4.62 31.14 -3.11%
  Suzhou Dongshan A CNE100000N79 4.21 25.50 -4.85%
  Brite Semiconductor Shanghai CNE100006JY3 4.19 68.60 -8.52%
  Cambricon Technologies CNE1000041R8 4.06 492.00 -4.34%
  Semiconductor M CNE1000041W8 3.64 88.77 -5.06%

Top Equity Funds by AXA SPDB Investment Managers Co.,Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  AXA SPDB CSI 300 Index Strengthen F 734.08M 13.02 -6.85 8.84
  AXA SPDB Consumption Upgrade Allo A 708.57M -2.23 -6.50 7.71
  AXA SPDB Consumption Upgrade Allo C 708.57M -2.34 -6.67 -
  AXA SPDB Dividend Selected Stock 562.51M -16.53 -14.01 8.24
  AXA SPDB Value Growth Equity A 515.52M 8.24 -15.42 2.86
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

519170 Comments

Write your thoughts about Axa Spdb Growth Flexible Allocate A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email